MMP1 and metastatic malignant neoplasm in the lymph nodes: In 2004, Matsumura and his coworkers firstly examined the contribution of MMP1 genotypes to GC risk [34], but findings that the genotypes were neither associated with the GC risk nor the prognosis such as lymph node metastasis and clinical stages.